These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 7636268
21. Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells. Taichman NS, Iwase M, Lally ET, Shattil SJ, Cunningham ME, Korchak HM. J Immunol; 1991 Nov 15; 147(10):3587-94. PubMed ID: 1940358 [Abstract] [Full Text] [Related]
22. Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense. Hadders MA, Beringer DX, Gros P. Science; 2007 Sep 14; 317(5844):1552-4. PubMed ID: 17872444 [Abstract] [Full Text] [Related]
23. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. Cesano A, Visonneau S, Clark SC, Santoli D. J Immunol; 1993 Sep 15; 151(6):2943-57. PubMed ID: 8104216 [Abstract] [Full Text] [Related]
24. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain. Brannen CL, Sodetz JM. Mol Immunol; 2007 Feb 15; 44(5):960-5. PubMed ID: 16624411 [Abstract] [Full Text] [Related]
25. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. Carney DF, Lang TJ, Shin ML. J Immunol; 1990 Jul 15; 145(2):623-9. PubMed ID: 2164064 [Abstract] [Full Text] [Related]
26. Molecular mechanisms of cytolysis by complement and by cytolytic lymphocytes. Podack ER. J Cell Biochem; 1986 Jul 15; 30(2):133-70. PubMed ID: 2422185 [No Abstract] [Full Text] [Related]
27. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage. Yoshida R, Sanchez-Bueno A, Yamamoto N, Einaga-Naito K. J Immunol; 1997 Jul 01; 159(1):15-21. PubMed ID: 9200433 [Abstract] [Full Text] [Related]
28. Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells. Lehmann C, Zeis M, Schmitz N, Uharek L. Blood; 2000 Jul 15; 96(2):594-600. PubMed ID: 10887123 [Abstract] [Full Text] [Related]
29. IL-4 induces protection of vascular endothelial cells against killing by complement and melittin through lipid biosynthesis. Black SM, Schott ME, Batdorf BH, Benson BA, Rutherford MS, Levay-Young BK, Dalmasso AP. Eur J Immunol; 2010 Mar 15; 40(3):803-12. PubMed ID: 20017192 [Abstract] [Full Text] [Related]
30. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. DeBlaker-Hohe DF, Yamauchi A, Yu CR, Horvath-Arcidiacono JA, Bloom ET. Cell Immunol; 1995 Oct 01; 165(1):33-43. PubMed ID: 7671323 [Abstract] [Full Text] [Related]
31. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid. Barton DP, Blanchard DK, Duan C, Roberts WS, Cavanagh D, DeCesare S, Djeu JY. J Soc Gynecol Investig; 1995 Oct 01; 2(6):762-71. PubMed ID: 9420887 [Abstract] [Full Text] [Related]
32. T-cell cytotoxicity of human Schwann cells: TNFalpha promotes fasL-mediated apoptosis and IFN gamma perforin-mediated lysis. Bonetti B, Valdo P, Ossi G, De Toni L, Masotto B, Marconi S, Rizzuto N, Nardelli E, Moretto G. Glia; 2003 Aug 01; 43(2):141-8. PubMed ID: 12838506 [Abstract] [Full Text] [Related]
33. Stably transfected antisense granzyme B and perforin constructs inhibit human granule-mediated lytic ability. Bochan MR, Goebel WS, Brahmi Z. Cell Immunol; 1995 Sep 01; 164(2):234-9. PubMed ID: 7656332 [Abstract] [Full Text] [Related]
34. Heat-shocked A20 lymphoma cells fail to induce degranulation of cytotoxic T lymphocytes: possible mechanism of resistance. Jackson KM, DeLeon M, Sistonen L, Verret CR. Cell Immunol; 2000 Jul 10; 203(1):12-8. PubMed ID: 10915557 [Abstract] [Full Text] [Related]
35. Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation. Daniels RH, Williams BD, Morgan BP. Immunology; 1990 Nov 10; 71(3):312-6. PubMed ID: 2269468 [Abstract] [Full Text] [Related]
36. Chimeric and truncated forms of human complement protein C8 alpha reveal binding sites for C8 beta and C8 gamma within the membrane attack complex/perforin region. Plumb ME, Scibek JJ, Barber TD, Dunlap RJ, Platteborze PL, Sodetz JM. Biochemistry; 1999 Jun 29; 38(26):8478-84. PubMed ID: 10387094 [Abstract] [Full Text] [Related]
37. Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity. Pilzer D, Saar M, Koya K, Fishelson Z. Int J Cancer; 2010 Mar 15; 126(6):1428-35. PubMed ID: 19739077 [Abstract] [Full Text] [Related]
38. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. Lewinsohn DM, Bement TT, Xu J, Lynch DH, Grabstein KH, Reed SG, Alderson MR. J Immunol; 1998 Mar 01; 160(5):2374-9. PubMed ID: 9498779 [Abstract] [Full Text] [Related]
39. Calcium-dependent protection from complement lysis in Naegleria fowleri amebae. Chu DM, Woodward J, Fritzinger A, Marciano-Cabral F. Cell Calcium; 2002 Mar 01; 31(3):105-14. PubMed ID: 12027384 [Abstract] [Full Text] [Related]
40. Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis. Kraus S, Seger R, Fishelson Z. Clin Exp Immunol; 2001 Mar 01; 123(3):366-74. PubMed ID: 11298121 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]